Employing a wide range of examples from G-protein-coupled receptors and ligand-gated ion channels, this detailed, single-source reference illustrates the principles of pharmacological analysis and receptor classification that are the basis of rational drug design.
Explains the experimental and theoretical methods used to characterize interactions between ligands and receptors-providing the pharmacological information needed to solve treatment problems and facilitate the drug design process!
Demonstrating the achievements of the receptor-based approach in therapeutics and indicating future directions, Receptor-Based Drug Design
Written by over 25 international authorities and containing nearly 1200 bibliographic citations, Receptor-Based Drug Design is a practical resource for pharmacologists, pharmacists, and pharmaceutical scientists; organic and medicinal chemists and biochemists; molecular biologists; biomedical researchers; and upper-level undergraduate and graduate students in these disciplines.
Introduction, James Black
Principles and Measurement of Drug-Receptor Interactions
The Characterization and Classification of Receptors, Patrick P. A. Humphrey
Functional Methods for Quantifying Agonists and Antagonists, Iain G. Dougall
Quantification of Receptor Interactions Using Binding Methods, Sebastian Lazareno
Drug Analysis Based on Signaling Responses to G-Protein-Coupled Receptors, T. Kendall Harden, José L. Boyer, and Robert W. Dougherty
The Use of Electrophysiology to Improve Understanding of Drug-Receptor Interactions, John G. Connolly and Charles Kennedy
Receptor-Based Drugs in Medicine
Selective Adrenergic and Glucocorticoid Treatments for Asthma, David Jack
Serotonin 5-HT1B/D Receptor Agonists, Graeme R. Martin
Histamine H2-Receptor Antagonists, Michael E. Parsons
Angiotensin Antagonists, Mark J. Robertson
Experimental and Emerging Drugs
-Adrenoceptor Agonists and Antagonists, J. Paul Hieble and Robert R. Ruffolo, Jr.
P2U-Purinoceptor Agonists: Emerging Therapy for Pulmonary Diseases, Eduardo R. Lazarowski, William C. Watt, T. Kendall Harden, and Richard C. Boucher
Muscarinic Receptor Antagonists Pharmacological and Therapeutic Utility, Richard M. Eglen
NMDA Receptor Antagonists, John A. Kemp and James N. C. Kew
New Trends in Drug Design
Computational Chemistry in Receptor-Based Drug Design, Ad P. IJzerman, Eleonora M. van der Wenden, and Wilma Kuipers
Recombinant G-Protein-Coupled Receptors as Screening Tools for Drug Discovery, A. Donny Strosberg and Prabhavathi B. Fernandes
Inverse Agonists and G-Protein-Coupled Receptors, Richard A. Bond and Michel Bouvier